BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11504742)

  • 1. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study.
    Grange F; Bekkenk MW; Wechsler J; Meijer CJ; Cerroni L; Bernengo M; Bosq J; Hedelin G; Fink Puches R; van Vloten WA; Joly P; Bagot M; Willemze R
    J Clin Oncol; 2001 Aug; 19(16):3602-10. PubMed ID: 11504742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
    Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
    J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related.
    Geelen FA; Vermeer MH; Meijer CJ; Van der Putte SC; Kerkhof E; Kluin PM; Willemze R
    J Clin Oncol; 1998 Jun; 16(6):2080-5. PubMed ID: 9626207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas.
    Grange F; Petrella T; Beylot-Barry M; Joly P; D'Incan M; Delaunay M; Machet L; Avril MF; Dalac S; Bernard P; Carlotti A; Esteve E; Vergier B; Dechelotte P; Cassagnau E; Courville P; Saiag P; Laroche L; Bagot M; Wechsler J
    Blood; 2004 May; 103(10):3662-8. PubMed ID: 14726400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognosis of primary cutaneous lymphomas].
    Grange F; Bagot M
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling.
    Hoefnagel JJ; Dijkman R; Basso K; Jansen PM; Hallermann C; Willemze R; Tensen CP; Vermeer MH
    Blood; 2005 May; 105(9):3671-8. PubMed ID: 15308563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases.
    Menguy S; Beylot-Barry M; Parrens M; Ledard AP; Frison E; Comoz F; Battistella M; Szablewski V; Balme B; Croue A; Franck F; Ortonne N; Tournier E; Lamant L; Carlotti A; De Muret A; Le Gall F; Lorton MH; Merlio JP; Vergier B
    Histopathology; 2019 Jun; 74(7):1067-1080. PubMed ID: 30715765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type.
    Pham-Ledard A; Beylot-Barry M; Barbe C; Leduc M; Petrella T; Vergier B; Martinez F; Cappellen D; Merlio JP; Grange F
    JAMA Dermatol; 2014 Nov; 150(11):1173-9. PubMed ID: 25055137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients.
    Bekkenk MW; Vermeer MH; Geerts ML; Noordijk EM; Heule F; van Voorst Vader PC; van Vloten WA; Meijer CJ; Willemze R
    J Clin Oncol; 1999 Aug; 17(8):2471-8. PubMed ID: 10561311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of central nervous system involvement in primary cutaneous B-cell lymphoma.
    Bekkenk MW; Postma TJ; Meijer CJ; Willemze R
    Cancer; 2000 Aug; 89(4):913-9. PubMed ID: 10951357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes.
    Goodlad JR; Krajewski AS; Batstone PJ; McKay P; White JM; Benton EC; Kavanagh GM; Lucraft HH;
    Am J Surg Pathol; 2003 Dec; 27(12):1538-45. PubMed ID: 14657713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma.
    Dijkman R; Tensen CP; Jordanova ES; Knijnenburg J; Hoefnagel JJ; Mulder AA; Rosenberg C; Raap AK; Willemze R; Szuhai K; Vermeer MH
    J Clin Oncol; 2006 Jan; 24(2):296-305. PubMed ID: 16330669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical study of primary cutaneous B-cell lymphoma using both the European Organization for Research and Treatment of Cancer and World Health Organization classifications.
    Yap LM; Blum R; Foley P; McCormack C; Turner H; Seymour JF; Prince HM
    Australas J Dermatol; 2003 May; 44(2):110-5. PubMed ID: 12752183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
    Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
    Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity.
    Paulli M; Viglio A; Vivenza D; Capello D; Rossi D; Riboni R; Lucioni M; Incardona P; Boveri E; Bellosta M; Orlandi E; Borroni G; Lazzarino M; Berti E; Alessi E; Magrini U; Gaidano G
    Hum Pathol; 2002 Sep; 33(9):937-43. PubMed ID: 12378521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems.
    Smith BD; Glusac EJ; McNiff JM; Smith GL; Heald PW; Cooper DL; Wilson LD
    J Clin Oncol; 2004 Feb; 22(4):634-9. PubMed ID: 14966086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases.
    Plaza JA; Kacerovska D; Stockman DL; Buonaccorsi JN; Baillargeon P; Suster S; Kazakov DV
    Am J Dermatopathol; 2011 Oct; 33(7):649-55; quiz 656-8. PubMed ID: 21937906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXP1 molecular cytogenetics and protein expression analyses in primary cutaneous large B cell lymphoma, leg-type.
    Espinet B; García-Herrera A; Gallardo F; Baró C; Salgado R; Servitje O; Estrach T; Colomo L; Romagosa V; Barranco C; Serrano S; Campo E; Pujol RM; Solé F
    Histol Histopathol; 2011 Feb; 26(2):213-21. PubMed ID: 21154235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma.
    van Galen JC; Hoefnagel JJ; Vermeer MH; Willemze R; Dijkman R; Tensen CP; de Boer WP; Meijer CJ; Oudejans JJ
    J Pathol; 2008 Jul; 215(3):340-6. PubMed ID: 18498125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.